Cargando…

Determining the ideal prevention strategy for multidrug-resistance organisms in resource-limited countries: a cost-effectiveness analysis study

The aim of this study was to determine the most cost-effective strategy for the prevention and control of multidrug-resistant organisms (MDROs) in intensive care units (ICUs) in areas with limited health resources. The study was conducted in 12 ICUs of four hospitals. The total cost for the preventi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ying, Yuan, Yufeng, Lin, Likai, Tan, Xiaodong, Tan, Yibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439291/
https://www.ncbi.nlm.nih.gov/pubmed/32430090
http://dx.doi.org/10.1017/S0950268820001120
_version_ 1783572948604420096
author Wang, Ying
Yuan, Yufeng
Lin, Likai
Tan, Xiaodong
Tan, Yibin
author_facet Wang, Ying
Yuan, Yufeng
Lin, Likai
Tan, Xiaodong
Tan, Yibin
author_sort Wang, Ying
collection PubMed
description The aim of this study was to determine the most cost-effective strategy for the prevention and control of multidrug-resistant organisms (MDROs) in intensive care units (ICUs) in areas with limited health resources. The study was conducted in 12 ICUs of four hospitals. The total cost for the prevention of MDROs and the secondary attack rate (SAR) of MDROs for each strategy were collected retrospectively from 2046 subjects from January to December 2017. The average cost-effectiveness ratio (CER), incremental cost-effectiveness ratio (ICER) and cost-effectiveness acceptability curve were calculated. Hand hygiene (HH) had the lowest total cost (2149.6 RMB) and SAR of MDROs (8.8%) while single-room isolation showed the highest cost (33 700.2 RMB) and contact isolation had the highest SAR of MDROs (31.8%). The average cost per unit infection prevention was 24 427.8 RMB, with the HH strategy followed by the environment disinfection strategy (CER = 21 314.67). HH had the highest iterative cost effect under willingness to pay less than 2000 RMB. Due to the low cost for repeatability and obvious effectiveness, we conclude that HH is the optimal strategy for MDROs infections in ICUs in developing countries. The cost-effectiveness of the four prevention strategies provides some reference for developing countries but multiple strategies remain to be examined.
format Online
Article
Text
id pubmed-7439291
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-74392912020-09-02 Determining the ideal prevention strategy for multidrug-resistance organisms in resource-limited countries: a cost-effectiveness analysis study Wang, Ying Yuan, Yufeng Lin, Likai Tan, Xiaodong Tan, Yibin Epidemiol Infect Original Paper The aim of this study was to determine the most cost-effective strategy for the prevention and control of multidrug-resistant organisms (MDROs) in intensive care units (ICUs) in areas with limited health resources. The study was conducted in 12 ICUs of four hospitals. The total cost for the prevention of MDROs and the secondary attack rate (SAR) of MDROs for each strategy were collected retrospectively from 2046 subjects from January to December 2017. The average cost-effectiveness ratio (CER), incremental cost-effectiveness ratio (ICER) and cost-effectiveness acceptability curve were calculated. Hand hygiene (HH) had the lowest total cost (2149.6 RMB) and SAR of MDROs (8.8%) while single-room isolation showed the highest cost (33 700.2 RMB) and contact isolation had the highest SAR of MDROs (31.8%). The average cost per unit infection prevention was 24 427.8 RMB, with the HH strategy followed by the environment disinfection strategy (CER = 21 314.67). HH had the highest iterative cost effect under willingness to pay less than 2000 RMB. Due to the low cost for repeatability and obvious effectiveness, we conclude that HH is the optimal strategy for MDROs infections in ICUs in developing countries. The cost-effectiveness of the four prevention strategies provides some reference for developing countries but multiple strategies remain to be examined. Cambridge University Press 2020-05-20 /pmc/articles/PMC7439291/ /pubmed/32430090 http://dx.doi.org/10.1017/S0950268820001120 Text en © The Author(s) 2020 http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Paper
Wang, Ying
Yuan, Yufeng
Lin, Likai
Tan, Xiaodong
Tan, Yibin
Determining the ideal prevention strategy for multidrug-resistance organisms in resource-limited countries: a cost-effectiveness analysis study
title Determining the ideal prevention strategy for multidrug-resistance organisms in resource-limited countries: a cost-effectiveness analysis study
title_full Determining the ideal prevention strategy for multidrug-resistance organisms in resource-limited countries: a cost-effectiveness analysis study
title_fullStr Determining the ideal prevention strategy for multidrug-resistance organisms in resource-limited countries: a cost-effectiveness analysis study
title_full_unstemmed Determining the ideal prevention strategy for multidrug-resistance organisms in resource-limited countries: a cost-effectiveness analysis study
title_short Determining the ideal prevention strategy for multidrug-resistance organisms in resource-limited countries: a cost-effectiveness analysis study
title_sort determining the ideal prevention strategy for multidrug-resistance organisms in resource-limited countries: a cost-effectiveness analysis study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439291/
https://www.ncbi.nlm.nih.gov/pubmed/32430090
http://dx.doi.org/10.1017/S0950268820001120
work_keys_str_mv AT wangying determiningtheidealpreventionstrategyformultidrugresistanceorganismsinresourcelimitedcountriesacosteffectivenessanalysisstudy
AT yuanyufeng determiningtheidealpreventionstrategyformultidrugresistanceorganismsinresourcelimitedcountriesacosteffectivenessanalysisstudy
AT linlikai determiningtheidealpreventionstrategyformultidrugresistanceorganismsinresourcelimitedcountriesacosteffectivenessanalysisstudy
AT tanxiaodong determiningtheidealpreventionstrategyformultidrugresistanceorganismsinresourcelimitedcountriesacosteffectivenessanalysisstudy
AT tanyibin determiningtheidealpreventionstrategyformultidrugresistanceorganismsinresourcelimitedcountriesacosteffectivenessanalysisstudy